Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFRxCD28 bispecific antibody (bsAb)

No Thumbnail Available

Date

2025

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Başkent Üniversitesi Tıp Fakültesi

Abstract

Description

Keywords

Citation

URI

https://hdl.handle.net/11727/14277

Collections

Tıp Fakültesi / Faculty of Medicine

Endorsement

Review

Supplemented By

Referenced By